Abstract

Using expression profiles from postmortem prefrontal cortex samples of 624 dementia patients and non-demented controls, we investigated global disruptions in the co-regulation of genes in two neurodegenerative diseases, late-onset Alzheimer's disease (AD) and Huntington's disease (HD). We identified networks of differentially co-expressed (DC) gene pairs that either gained or lost correlation in disease cases relative to the control group, with the former dominant for both AD and HD and both patterns replicating in independent human cohorts of AD and aging. When aligning networks of DC patterns and physical interactions, we identified a 242-gene subnetwork enriched for independent AD/HD signatures. This subnetwork revealed a surprising dichotomy of gained/lost correlations among two inter-connected processes, chromatin organization and neural differentiation, and included DNA methyltransferases, DNMT1 and DNMT3A, of which we predicted the former but not latter as a key regulator. To validate the inter-connection of these two processes and our key regulator prediction, we generated two brain-specific knockout (KO) mice and show that Dnmt1 KO signature significantly overlaps with the subnetwork (= 3.1 × 10−12), while Dnmt3a KO signature does not (P = 0.017).

Details

Title
Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases
Author
Manikandan Narayanan 1 ; Huynh, Jimmy L 2 ; Wang, Kai 3 ; Yang, Xia 4 ; Yoo, Seungyeul 5 ; McElwee, Joshua 3 ; Zhang, Bin 5 ; Zhang, Chunsheng 3 ; Lamb, John R 3 ; Xie, Tao 3 ; Suver, Christine 6 ; Molony, Cliona 3 ; Melquist, Stacey 3 ; Johnson, Andrew D 7 ; Fan, Guoping 8 ; Stone, David J 3 ; Schadt, Eric E 5 ; Casaccia, Patrizia 2 ; Emilsson, Valur 9 ; Zhu, Jun 5 

 National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA 
 Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA 
 Merck Research Laboratories, Merck & Co., Inc., Whitehouse Station, NJ, USA 
 Department of Integrative Biology and Physiology, University of California, Los Angeles, CA, USA 
 Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA 
 Sage Bionetworks, Seattle, WA, USA 
 National Heart, Lung and Blood Institute, Bethesda, MD, USA 
 Department of Human Genetics, University of California, Los Angeles, CA, USA 
 Icelandic Heart Association, Kopavogur, Iceland; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland 
Section
Articles
Publication year
2014
Publication date
Jul 2014
Publisher
EMBO Press
e-ISSN
17444292
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2290026808
Copyright
© 2014. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.